Category

PR

惠淘科技有限公司完成对尚慧国际教育集团有限公司的收购

By | PR, SC

北京2020年2月18日 /美通社/ — 惠淘科技有限公司(NASDAQ交易代码:HHT,以下简称“公司”),主要从事高级预拌混凝土和建筑材料的研发、生产、运输和泵送业务。公司于今天宣布其于2020年2月14日完成了对尚慧国际教育集团有限公司(以下简称“尚慧国际”)的收购,尚慧国际总部设在中国,是一个教育服务提供商。

按照修订后的收购协议,公司将从尚慧国际的股东处获得尚慧国际100%的股权,尚慧国际将成为公司的全资子公司。尚慧国际的股东麻建、WU RACHEL YI XIU将获得总数为1,989,262股的公司股票,并在五年期限内根据为尚慧国际设立的财务目标之完成情况按年获得现金回报,现金回报总额不超过200万美金。

公司的首席执行官Yang Liu先生(Sean)指出:“这一收购的完成对于公司意义重大,将极大拓展公司的业务机会并最大化公司对于股东的价值。目前中国对于智慧教育的需求日益剧增,尚慧国际在将机器人技术和人工智能运用于早期幼儿教育上拥有专业经验,我们作为上市公司看到和尚慧国际的合并将创造很多市场机会和价值。我们的愿景是利用尚慧国际这一平台来扩展我们的业务线。”

尚慧国际的总经理Mr. Liming Lu指出:“我们非常高兴和惠淘达成此次合作并为此次合作机会感到激动,本次合作的成功实施,帮助我们与资本市场完成了对接,使得我们所从事的有价值的事业能与更多的投资人分享收益。”

目前教育智能化、在线教育已经获得家庭、教育机构、社会的广泛认可,在线教育市场正在爆发式增长,我们将进一步加强与教育机构的合作,扩大在线教育的整体业务规模,我们希望在未来3年内为超过1000万个家庭提供在线教育服务,并为更多的教育机构提供教育智能化升级服务,我们将努力为教育机构、家庭提供更多、更好的教育服务,为投资人创造更多的价值回报。

关于惠淘科技有限公司

本公司从事用于大型基础设施、商业和住宅开发的高级建筑材料的生产。本公司主要专注于工程、生产、服务、交付和泵送各种先进的预拌混凝土材料,以用于高科技、大型和环保的建设项目。预拌混凝土产品是重要的建筑材料,可用于绝大多数商业,住宅和公共工程建设项目。我们致力于拓展自身业务,并着重于广泛使用可回收的废料,延长产品寿命,在最小化能源消耗的基础上高效生产混凝土材料,减少粉尘和空气污染并持续创新产品、生产方法与实践。

前瞻性陈述

本文稿中的某些陈述含有1995年《私人证券诉讼改革法案》“安全港”条款所指的“前瞻性陈述”。前瞻性陈述一般使用“预期”,“相信”,“期望”,“估计”,“计划”,“展望”和“项目”以及其他类似的表达方式,用于预测或指示未来的事件或趋势,并非对历史事项的陈述。这些前瞻性陈述包括拟议交易的时机;交易完成后,双方的商业计划,目标,期望和意图,以及HHT的预计未来经营成果、商业策略、竞争地位、行业环境和潜在增长机会。这些前瞻性陈述反映了对现有信息的当前分析,并受到各种风险和不确定性因素的影响。因此,在依赖前瞻性陈述时必须谨慎。由于已知与未知的风险,我们的实际结果可能与预期结果存在重大出入。所有属于本公司或代表本公司所作的前瞻性陈述均受这些风险的影响。除证券法所规定外,本公司不承担更新这些前瞻性陈述的责任。

以下因素可能会导致实际结果与前瞻性陈述中所述结果产生重大出入:可能引起换股协议条款变化且未载于任何最终协议里的任何事件、变更或其他情况的发生;在披露换股协议和并购交易后,针对HHT或换股协议其他方已有或将被提起的任何法律程序的结果;在并购交易开始与交割后HHT满足纳斯达克上市标准的能力;由于成交条件未能被全部满足而无法完成收购;由于宣布了换股协议并完成了其中所述的交易,而产生的对本公司当前计划和运营以及员工保留的潜在困难;与拟并购交易有关的费用;适用法律或法规的变更;合并后公司实现其财务和战略目标的能力,合并后公司增长和管理增长获利能力,维持与客户的关系以及保留其关键雇员的能力;合并后的公司受到其他经济,业务和/或竞争因素的不利影响的可能性;以及HHT向美国证券交易委员会(“SEC”)提交的其他报告和其他公开文件中讨论的风险与不确定因素。

有关可能影响我们的期望和预测的风险因素的其他信息,可在我们向SEC提交的定期报告中找到,包括我们截至2019年6月30日的20-F财报。HHT的SEC文件可在SEC网站www.sec.gov上公开获取。 HHT不承担任何因新信息、未来事件或其他原因而更新前瞻性陈述的义务。

需要更多信息,请联系:

Yang Liu先生(Sean),首席执行官
惠淘科技有限公司
邮件:
[email protected]

Are you a Corporate Representative of 惠淘科技有限公司, an investor, or a member of the Business Press?



iClick Interactive Acquires Majority Interest in Optimal Power Limited

By | EN, PR

HONG KONG, Feb. 18, 2020 /PRNewswire/ — iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that, subject to certain closing conditions, it has agreed to acquire an 80% equity interest in Optimal Power Limited ("Optimal Power"), a subsidiary wholly owned by Creative Big Limited ("Creative Big"), both incorporated under the laws of the British Virgin Islands. Creative Big is wholly owned by Mr. Kenny Sin Nang CHIU ("Mr. CHIU"), a veteran businessman in Asia. Creative Big has secured a network of premium media licensing assets in countries including Singapore, Greater China (including Hong Kong), Australia, India, Indonesia, Philippines and Malaysia and as part of the transaction, Creative Big would inject the selected media licensing assets into Optimal Power.

Mr. CHIU, who has over 30 years of experience in the business field and has served as a member on boards of directors for a number of Hong Kong listed companies, across various industries. His strong network has helped build up the premium media licensing assets that Creative Big owns today. The Company will finance the acquisition through the issuance of certain number of American Depository Shares (the "ADSs") at a price of US$3.9 per ADS, which is 7% premium to the 14-day VWAP as of 14 February 2020. 

"This transaction represents an exciting step for our company. The success of such execution will not only give us the ability to enrich our offerings, but also a vital step toward our profitability improvement this year," said Jian "T.J." Tang, iClick’s Chief Executive Officer and Co-Founder.

About iClick Interactive Asia Group Limited

iClick Interactive Asia Group Limited (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, iClick’s proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in ten locations worldwide including Asia and Europe.

For more information, please visit ir.i-click.com.

About Creative Big Limited

Creative Big provides digital marketing resources in various fields, including digital marketing channels, content marketing and social media marketing. In addition to acquisitions and strategic investments, Creative Big promotes the early development of new business models with its media resources and experience.

Safe Harbor Statement

This announcement contains forward-looking statements, including those related to the Company’s business strategies, operations and financial performance. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Such statements are based upon management’s current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s fluctuations in growth; its success in implementing its mobile and new retail strategies, including extending its solutions beyond its core online marketing business; its success in structuring a CRM & Marketing Cloud platform; relative percentage of its gross billing recognized as revenue under the gross and net models; its ability to retain existing clients or attract new ones; its ability to retain content distribution channels and negotiate favorable contractual terms; market competition, including from independent online marketing technology platforms as well as large and well-established internet companies; market acceptance of online marketing technology solutions and enterprise solutions; effectiveness of its algorithms and data engines; its ability to collect and use data from various sources; ability to integrate and realize synergies from acquisitions, investments or strategic partnership; fluctuations in foreign exchange rates; and general economic conditions in China and other jurisdictions where the Company operates; and the regulatory landscape in China and other jurisdictions where the Company operates. Further information regarding these and other risks is included in the Company’s annual report on Form 20-F and other filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

In China:

In the United States:

iClick Interactive Asia Group Limited

Core IR

Lisa Li

John Marco

Phone: +86-21-3230-3931 #892

Tel: +1-516-222-2560

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/iclick-interactive-acquires-majority-interest-in-optimal-power-limited-301006526.html

Related Links :

http://ir.i-click.com

www.optaim.com

Are you a Corporate Representative of iClick Interactive Asia Group Limited, an investor, or a member of the Business Press?



海亮教育发布2020年主席新年致辞

By | PR, SC

杭州2020年2月18日 /美通社/ — 海亮教育集团有限公司(纳斯达克股票代码:HLG)(以下简称“海亮教育”、“公司”或“我们”),一家中小学教育管理服务提供商,于今日发布2020年海亮教育董事会主席致各位股东的信。

尊敬的各位股东:

2019年,海亮教育坚持以“精品化”、“特色化”、“国际化”为发展定位,通过基础教育、艺术教育、国际教育打造高端的海亮教育品牌。2019财年,海亮教育实行“以轻资产为主,轻重并举”的发展模式,在持续夯实既有业务的同时,不断开拓新的业务模式,取得了骄人的经营业绩。收入和净利润创新高,相较去年分别同比增长28.2%和36.8%,高成长性为股东带来了可观的回报。截至2019年6月30日,海亮教育的办学网络扩张至36所学校,其中包含自主举办的9所学校和运营管理的27所学校;在校学生人数共计61,109人,其中自主举办学校的学生总人数达22,819人。在2019财年,海亮教育继续积极推进国际化办学,国际教育学生人数同比增长15%至4,553人,带动其业务收入大幅增长25%至4.1亿元人民币;同时,海亮教育推出了教育培训业务、海外留学业务和研学业务等多种补充教育服务,以此扩展收入来源,使公司业务更加多元化。

2020财年已经过半,在中国传统新年结束之际,我很荣幸地向股东汇报海亮教育2020财年已取得的显著成绩和新年发展概况。

创新人才培养,优化人才结构

2019年4月成立了海亮教育干部铁军学校,以打造学校管理人才孵化营为使命,为海亮教育工作的教师和其他专业人员提供了专业培训计划,目前聘任导师47名,选拔学员107人。截至2019年12月31日,已有41人获得挂职锻炼,并向总部地区以外输出干部14人。2019年8月了成立海亮名师发展学校,通过师徒结对、学员三年规划制定等项目开展名师培养工程。截至2019年12月31日,聘任内部导师26名、外部导师11名,选拔学员86人。

海亮教育不断推动人才结构优化,2019年校招录用的毕业生中,有34%来自于双一流学校,其中包含清华大学及北京大学30人。校招录用的毕业生中,硕士及以上学历占26%,其中双一流高校的硕士毕业生占比77%。

教学质量再提高,学术成果显著

在2019年中考中,海亮教育自主举办学校的学生取得了优秀的学术成绩,共有18名进入诸暨市前20名,275名学生达到了685分及以上分数(满分770分)。此外,我们的1名学生荣获了诸暨市中考最高分731分;在2019年高考中,海亮教育自主举办学校的学生获得了诸暨市最高分,有2位同学分别被清华大学和北京大学录取;18位同学通过了清华大学、北京大学、复旦大学、上海交大、浙江大学等高水平大学自主招生、三位一体笔试和面试;2019年,公司自主举办学校的国际教育毕业班共计284名学生,其中283名学生都收到了海外大学的录取通知书,41%的学生获得了世界前100大学的录取通知书,其中包括帝国理工学院伦敦大学学院等。海亮外国语学校的39名毕业生,全部获得了世界排名前100名校录取通知书,72%获世界前30名校录取,26%获世界前10名校录取。

2019财年,HSK项目1名国际学生被清华大学录取,8名国际学生被浙江大学录取,其他录取学校还包括复旦大学、南京大学、西南大学、中国美术学院和上海外国语大学等中国知名高等学府。

2019年,我们学生的学科竞赛成绩硕果累累。我们分别夺得第35届全国中学生物理竞赛金牌1块、第35届全国中学生数学竞赛金牌1块、银牌2块。“五大学科”竞赛中我们累计获得全国一等奖22人次,二等奖65人次,三等奖35人次,其中有8位同学因竞赛成绩优秀已经与北京大学、清华大学签约。

我们也非常注重学生的身心健康,举办丰富的体育活动,鼓励学生参加多种体育竞赛。2019年,我们的学生分别获得第十四届亚洲射击锦标赛冠军,浙江省青少年射击冠军赛5枚金牌、5枚银牌、5枚铜牌;在全国第二届青年运动会、全国英式7人制橄榄球锦标赛中均获亚军,还分别获得浙江省中学篮球联赛初中组冠军、全国U14男子篮球联赛亚军。

收获国内外多项大奖,品牌影响力持续扩大

在2020上半财年,海亮教育荣获多项大奖,包括2019第八届中国财经峰会颁发的“2019杰出品牌形象奖”,2019中国财经峰会冬季论坛暨2019全球新商业大会颁发的“2019年度创新引领奖”,2019年海亮教育荣登《巴伦周刊》“ 2019中概股最具投资价值TOP50”榜单。

持续推进跨区域合作办学,培训业务稳步扩张,促进多元化业务发展

2019年7月16日,公司与甘肃省兰州市城关区人民政府签订了合作办学协议,新设1所自主举办学校,名称为兰州海亮实验学校,办学层次为小学和初中,容纳学生人数约为2000余人,预计将在2020年9月开学。

继2019年7月9日我们与江苏省宿迁市泗洪县教育局签署委托办学合作协议,托管江苏省宿迁市泗洪县第二实验学校后,2020年1月12日,我们与江苏省国家级开发区宿迁经济技术开发区管委会签订了合作办学协议,将运营管理2所公办学校。两所学校分别为“厦门路学校”和“富民大道学校”,办学层次为小学和初中,公司预计将在2020年7月介入学校托管,预计两所学校学位数共计近6000人。

此外,根据公司与海亮集团有限公司(“海亮集团”)、海亮教育投资集团有限公司(“教育投资”)签署的三方战略协议,海亮集团和教育投资新建、收购兼并、受托管理的民办、公办中小学校,将全面委托海亮教育运营管理。2019年11月27日,海亮集团和浙江省宁波市宁海县跃龙街道办事处签订了合作办学协议,新设1所学校,暂定名称为宁海公学,办学层次为小学、初中、高中,容纳人数约为4000余人,预计将在2021年秋季开学;2019年12月28日,海亮集团和安徽省芜湖市人民政府签订合作办学协议,新设1所自主举办学校,暂定名称为芜湖海亮实验学校,办学层次为小学、初中、高中,容纳人数约为4000余人,预计将在2020年9月部分开学。

2020年,公司将围绕K12教育,深入教育培训市场,包含学科辅导、少儿英语和艺术类课程等,打通线下培训和在线教育课程,创建线上线下和谐共生的课外学科培训铭优品牌。目前已经拥有杭州和诸暨2个校区,今后将在每所学校所在地,依法设立独立的培训机构。海亮铭优始终坚持以产品为王,创建和打通线下培训和在线教育课程,进一步提升市场渗透率。

提高海亮教育国际教育市场站位,升级国际招生计划,国际化步伐愈发坚定

海亮教育于2020年1月成立国际留学生院,面向境外招收小初高的国际学生,扩大国际生比例。公司还开设了“一带一路”国际英才留学中国公益项目,打造海亮“国际英才”培养模式,招收更多有意向到中国留学的国际学生来海亮教育学习。目前,国际留学生院的小学和初中开设以英式课程为主的中西融合课程;国际留学生院的高中则根据学生的大学申请方向为其量身定制不同的学习计划和课程。对于想申请中国大学的国际学生,学校将为学生规划学术路线申请中国双一流高校,如准备HSK等级考试等;对于想申请海外高校的国际学生,学校将为学生提供IGCSE和A-Level课程,旨在提升学生竞争力,助力学生进入全球顶尖名校。

公司积极参加抗击疫情公益活动,履行上市企业责任

面对国内新型冠状病毒肺炎疫情,海亮教育在第一时间成立疫情防控应急领导小组,整体把控,部署预案,明确学校责任,措施周全,层层落实防控工作;积极参与海亮集团、浙江海亮慈善基金会为抗击疫情捐赠善款活动,所募集的善款将全部用于采购防疫急需物资、慰问一线医护人员和志愿者、救助疫情中出现的困难家庭等公益项目,海亮教育和全社会一道勇于抗击疫情,共克时艰。

依托丰厚的教育资源、强大的师资力量和技术力量,公司搭建起联通家校的在线课堂 — 海亮教育VIP云端教室。在云端教室,孩子们将参与原班级原任课教师VIP定制的在线直播课,授课教师将为学生答疑解惑;海亮教育旗下K12培训品牌 — 海亮铭优,汇聚名师力量,依托互联网技术,免费向全国中小学生提供覆盖全年段全学科的专属视频课程,并提供科学、高效的指导,做到“防疫不误学,停课不停学”。

公司密切关注有关疫情的最新动态,提前筹备春季学期开学事宜,并已全面开放2020年秋季新生参观体验预约系统,根据教育部门统一安排的开学日期,与每一位预约报名的家长朋友确定参观体验时间;作为民办教育行业的翘楚,在此特殊时期,公司已全面开放“海亮教育教职工招聘在线预约系统”,愿意为社会提供更多的教育工作岗位,为学校发展蓄力。

没有一个冬天不可逾越,没有一个春天不会来临。在辞旧迎新之际,本人谨代表公司董事会,衷心感谢信任并支持公司发展的广大学生、家长!衷心感谢为公司发展努力拼搏的全体董事会成员及高级管理层、教师及员工!衷心感谢一直以来支持和关怀公司发展的各位股东!公司将扎根于中国民办教育市场,积极加快国际化办学步伐,不忘初心,创造性地践行“人皆英才、人人成才,让每个生命出彩”的教育理念,为努力实现海亮教育创始人冯海良先生的让学生“学得更快乐、身体更健康、知识更丰富、升学更理想”,使公司做到让“家长更满意、品牌更响亮、效益更可观、老师更自豪”的办学理想而全力打拼、砥砺前行。

汪鸣
董事会主席兼首席执行官
海亮教育集团有限公司

关于海亮教育集团有限公司

海亮教育(纳斯达克股票代码:HLG)是中国最大的中小学教育运营服务商之一。海亮教育紧紧围绕“精品化、特色化、国际化”的办学目标,致力于为学生提供优质的中小学和国际教育服务,注重学生的生命质量、学习质量和发展质量。因材施教,力求学生的学习能力、文化素养、国际视野出类拔萃。实现中、英、西、日、韩、法多语种教学,开设奥赛、英国A-Level、澳大利亚VCE、雅思、托福、SAT等多元化精品课程,与全球200多所国际教育机构和院校建立了广泛的合作关系。海亮教育努力为学生提供更多进入国内外知名院校继续深造的机会。更多信息,请浏览:http://ir.hailiangedu.com/

免责声明

本公告包含1995年“私人证券诉讼改革法案”安全港条款含义范围内的前瞻性陈述。此篇新闻稿包含海亮教育对未来预期、计划和前景所构成的前瞻性陈述看法。除本公告中的历史事实陈述外,所有陈述均为前瞻性陈述,包括但不限于以下几点:中国的整体经济和商业条件;中国教育行业及中国民办教育市场的趋势与竞争;中国政府有关私立教育服务的政策和服务提供者;中国爆发的流行病和其他突发性情况;本公司业务战略和举措以及公司的业务计划;本公司未来业务发展,经营业绩及财务状况;预期公司收入及若干成本或费用项目的变动;筹集额外资金的能力,维护和发展业务的能力,经营业绩的变化,维护和提升品牌的能力,开发和引进新产品及服务;为委托方提供管理服务所覆盖的学生人数;将收购的公司、技术和资产成功整合到其服务组合中;营销等业务发展举措,行业竞争,一般政府监管,经济条件,对关键人员的依赖、吸引、聘用和留住,关键人员指具备满足客户要求所需的技术和经验的人员的能力及其保护知识产权的能力;正在进行的或将来的任何诉讼或仲裁的结果,包括有关版权和其他知识产权的结果;以及本公司向证券交易委员会提交的文件中详述的其他风险。海亮教育也可能在提交给美国证券交易委员会的报告,向股东提交的年度报告,新闻稿和其他书面材料以及公司高管、董事、职员向第三方提供的口头和书面陈述中包含前瞻性陈述。非历史事实的陈述,包括有关海亮教育的信念和期望的陈述,均属前瞻性陈述。这些前瞻性陈述涉及已知和未知的风险和不确定性,并基于对公司认为可能影响其财务状况,经营业绩,业务战略和财务需求的未来事件和财务趋势的当前预期和预测。投资者可以通过“可能”,“将”,“将会”,“将使”,“预计”,“期望”,“目标”,“估计”,“打算”,“计划”,,“相信”,“潜在”,“继续”,“力争”,“有可能”等单词或短语或其他类似表达来识别这些前瞻性陈述。有关这些和其他风险的更多信息,请参阅我们向证券交易委员会提交的20-F表格和其他文件的年度报告。本新闻稿及附件中包含的所有信息均为截至本新闻稿日期的现下信息。除非适用法律要求,否则海亮教育没有义务更新这些信息。

更多信息请联系:

丘立涛
董事会秘书
海亮教育集团有限公司
电话:+86-571-5812-1974
邮件:[email protected] 

Tina Xiao
总裁
埃森德投资者关系公司
电话:+1-917-609-0333
邮件:[email protected] 

相关链接 :

http://ir.hailiangedu.com/

Are you a Corporate Representative of 海亮教育集团, an investor, or a member of the Business Press?



Hailiang Education Releases 2020 Chinese New Year Chairman Letter

By | EN, PR

HANGZHOU, China, Feb. 18, 2020 /PRNewswire/ — Hailiang Education Group Inc. (Nasdaq: HLG) ("Hailiang Education", the "Company" or "we"), an education and management service provider of primary, middle, and high schools in China, today released a letter to shareholders from the chairman of the Company’s board of directors.

Dear Shareholders,

In 2019, Hailiang Education has adhered to its development goal of providing distinguished, specialized, and internationalized education. It has built a high-end education brand through its basic educational program, international program, and art educational program. In the fiscal year 2019, Hailiang Education has implemented a hybrid development strategy, which combines an asset-light model and strategic acquisitions, to improve brand recognition and explore market opportunities. We have achieved positive operating results, both from existing businesses and new business models. In fiscal year 2019, our revenue and net income increased by 28.2% and 36.8% respectively as compared to the previous fiscal year, which brought considerable investment returns to our shareholders. As of June 30, 2019, Hailiang Education has extended its network to 36 schools including 9 affiliated schools and 27 managed schools. The aggregate number of students enrolled in both our affiliated and managed schools has reached 61,109, among which 22,819 students came from our affiliated schools. As we continued to promote education internationalization, the number of students enrolled in the international program increased by 15% to 4,553, and the revenue generated by the international program increased by 25% to RMB410 million in the fiscal year 2019. At the same time, Hailiang Education has launched a variety of ancillary education services, such as educational training, study trip, and overseas study consulting services to diversify the Company’s businesses and increase its earnings.

The first half of the fiscal year 2020 has already passed. I am very excited and delighted to share the Company’s recent achievements and outlook with our shareholders.

Strengthen Talent Pool

With the mission of nurturing talents specializing in school management, Hailiang Education Cadre Army Institute (the "Cadre Institute") was founded in April 2019 and has provided professional training programs to teachers and other professionals working for Hailiang Education. The Cadre Institute currently has 47 mentors and 107 trainees. As of December 31, 2019, 41 teachers completed the trainee programs provided by the Cadre Institute, 14 of whom have been appointed to various intuitions within the Hailiang Education Group. In August 2019, we further established the Hailiang Great Teacher Development Institute ("the Great Teacher Institute") to implement the "Great Teachers Training Project," which is to train great teachers through initiatives such as mentor-trainees pairing and trainees’ three-year planning. As of December 31, 2019, the Great Teacher Institute has 26 internal mentors, 11 external mentors, and 86 trainees.

We also have kept on optimizing the talent structure of our teaching staff. For all the candidates we recruited on campus in 2019, 34% of them came from the Double-First Class University List, a selected list of Chinese universities and colleges which participate in the construction plan of world-class universities. Specifically, 30 candidates came from Tsinghua University and Peking University. For all the candidates we recruited in 2019, 26% of them had a master degree or above and 77% of them graduated from the Double-First Class University List.

Improved Teaching Quality Contributed to Remarkable Academic Results

With respect to the 2019 middle school entrance examination ("2018/2019 Zhongkao"), our students have achieved outstanding academic performance. Eighteen of our students placed in the Top 20 student ranking in Zhuji city, Zhejiang Province, while 275 of our students scored 685 points and above out of 770 points (the total score of the examination). In particular, one of our students scored 731 points, the highest score in Zhuji City, Zhejiang Province. With respect to the 2019 college entrance examination ("2018/2019 Gaokao"), one of our students achieved the highest score in Zhuji city, while two of our students were admitted into Tsinghua University and Peking University, respectively. Eighteen of our students passed the high-level universities’ independent admission examination, including Tsinghua University, Peking University, Fudan University, Shanghai Jiaotong University and Zhejiang University. In the 2019 graduate class of our affiliated schools, 284 students in our international programs applied for overseas universities, among which 283 students have received offers. Furthermore, 41% of these students received offers from the Global Top 100 Universities, such as Imperial College London and University College London. All 39 graduates of Hailiang Foreign Languages School (HFLS) received offers from the Global Top 100 Universities. Specifically, 72% and 26% of these offers were from the Global Top 30 Universities and the Global Top 10 Universities, respectively.

In the fiscal year 2019, one of our international students from our HSK program ("the Chinese Proficiency Test") was accepted by Tsinghua University and eight international students were accepted by Zhejiang University. Our graduates of HSK program also received admissions from other well-known universities in China, including Fudan University, Nanjing University, Southwest University of China, China Academy of Art, and Shanghai International Studies University.

In 2019, we also made progressive achievements in terms of academic competitions. Our students won a Gold Medal at the 35th National Physics Competition, as well as a Gold Medal and two Silver Medals at the 35th National Math Competition. In the "Five Major-Subject" Competition, which includes Math, Physics, IT, Chemistry, and Biology, 22 of our students were awarded first-prize, 65 of them were awarded second-prize, and 35 of them were awarded third-prize. Tsinghua University and Peking University have selected eight of our students who were outstanding in academic competition.

We value our students’ mental and physical health, demonstrated by multiple physical activates offered by us and our principle of encouraging students to participate in athletic contests. In 2019, our students have won the first prize of 14th Asian Shooting Championship, as well as five Gold Medals, five Silver Medals, and five Bronze Medals in the Zhejiang Youth Shooting Championship, respectively. Our students also won the second prize in the 2nd National Youth Games and National 7-man Rugby Championships respectively, the first prize in the junior high school championship of the Zhejiang Middle School Basketball League, and the second prize in the National U14 Men’s Basketball League.

Multiple Awards Received and Brand Recognition Increased

In the first half of the fiscal year 2020, Hailiang Education received multiple awards, including the "2019 Outstanding Brand Image Award" awarded by the Eighth China Finance and Economic Summit in 2019 and the "2019 Innovation Leadership Award" awarded by the 2019 China Finance Summit Winter Forum (2019 New Global Business Conference). Hailiang Education was listed on Barron’s "Top 50 Most Investment-Worthy Chinese Stocks in 2019."

Continue to Promote Cross-Regional School Cooperation, Steadily Expand the Training Services, and Diversify Business Development

On July 16, 2019, we entered into a cooperation agreement with the People’s Government of Chengguan District, Lanzhou City, Gansu Province to establish and operate an affiliated school named Lanzhou Hailiang Experimental School. The school will have a capacity of approximately 2,000 students and is composed of a primary school program and a middle school program. The school is expected to start operating in September 2020.

We signed a school cooperation agreement with the Education Bureau of Sihong County, Suqian City, Jiangsu Province on July 9, 2019, pursuant to which the Company has acquired the right to operate the Sihong Second Experimental School of Sihong County at Suqian city in Jiangsu. Furthermore, on January 12, 2020, we entered into a cooperation school operating agreement with the Management Committee of Suqian Economic and Technological Development Zone of Jiangsu Province National Development Zone, pursuant to which the Company has acquired the right to operate two public schools tentatively named "Xiamen Road School" and "Fumin Avenue School." These two schools will have a cumulative capacity of about 6,000 students and will be composed of primary and middle school programs. The two schools are expected to start operating in July 2020.

Besides, pursuant to the three-party strategic cooperation agreement we entered into with Hailiang Group and Hailiang Education Investment Group, we have a priority right to operate and manage such schools established by both Hailiang Group and Hailiang Education Investment Group through construction, merger and acquisition, and cooperation with third-parties. On November 27, 2019, Hailiang Group signed a cooperative school operating agreement with the Yuelong Sub-district office in Ninghai County, Ningbo City, Zhejiang Province to establish and operate a new school tentatively named Ninghai Public School. The school has a capacity of about 4,000 students and is composed of primary, middle and high school programs. The school is expected to start operating in the fall of 2021. On December 28, 2019, Hailiang Group signed a cooperative school operating agreement with the Wuhu Municipal People’s Government of Anhui Province to establish and operate a new affiliated school tentatively named Wuhu Hailiang Experimental School. The affiliated school will have a capacity of about 4,000 students and is composed of primary, middle and high school programs. The school is expected to partially start operating in September 2020.

In 2020, the Company will focus on K12 education market in China while exploring the education and training market sector specifically focusing on tutoring, English learning, and art education for children in China. The Company also plans to integrate its offline training programs with online courses and launch "Hailiang Mingyou", an online and offline extracurricular training brand. At present, we have initiated Hailiang Mingyou programs in Hangzhou and Zhuji City, Zhejiang Province. In the future, we will set up independent Hailiang Mingyou training institutions on each of our school campuses. Hailiang Mingyou will always commit itself to focus on product development and develop offline training and online courses in order to increase its market penetration further.

Enhance Our International Education Market Position, Upgrade Our International Enrollment Plan, And Implement Our Internationalized Development Strategy

In the fiscal year 2020, Hailiang Education started operating International Student College in January 2020 and will continue its efforts to recruit international students for its primary, middle and high school programs in order to increase the number of international students in its entire student body. The Company has also launched "The Belt and Road International Talents Study-in-China Philanthropic Program", which is a charitable project created to allow a larger number of international talents to study in China. The Company has built a proprietary international talents training model to attract international students to study at schools of Hailiang Education. Currently, the primary and middle school programs of International Student College offer Chinese-Western integration courses, which are mainly based on British courses. The high school program of our International Student College offers students different study plans and curriculums tailored to their interests in pursuing higher education programs in their senior year. For international students interested in applying to Chinese domestic universities, the high school program offers them an academic track preparing them for examinations necessary for applying to China’s top universities, such as the HSK level test. For students interested in applying to international universities, the high school program offers IGCSE and A-Level courses designed to increase students’ competitiveness in applicant pools and prepare them to enter top universities in the world.

Participate in Philanthropic Events to Fight Against The COVID-19[1] and Take on Its Responsibilities as a Public Company

Facing the outbreak of the COVID-19, Hailiang Education immediately established the "Coronavirus Prevention and Control Management Team" to handle the overall situation within the Company, devise and execute preventive plans , specify responsibilities at the school level, and implement comprehensive steps designed to prevent and control the development of the coronavirus at various levels. The Company also actively participated in donation events organized by Hailiang Group and Zhejiang Hailiang Charity Foundation. All the funds raised in such events will be used to fight against the epidemic, including procuring urgently needed supplies, providing public welfare fund for frontline medical staff and volunteers, and providing financial aids to families in need during the epidemic. Hailiang Education has promised to combat the epidemic and overcome the difficulties together with the whole Chinese society.

Relying on its abundant educational resources, outstanding facility capabilities, and technical advantages, the Company has set up an online platform – "Hailiang VIP Cloud Classroom" – to connect teachers with students. Connected through such platform, students are able to participate in online live lessons instructed by their teachers, and teachers are able to provide students with answers and guidance to any problem students have encountered during class. Hailiang Mingyou will also provide primary, middle, and high school students in China with free video courses covering various subjects. These video courses provide students with scientific and efficient guidance due to the epidemic.

The Company pays close attention to the ongoing epidemic, prepares for the new spring semester in advance, and provides an active appointment system that allow parents to register for our fall 2020 freshman school tour. We will confirm the visiting time with all the parents who registered for such tour based on the semester starting date determined by the Ministry of Education of the People’s Republic of China. As an industry leader in private education, Hailiang Education will leave its "Hailiang Education Faculty Recruitment Online Reservation Window" open and aim to release more openings for the public during this epidemic period.

On behalf of Hailiang Education, I would like to express my sincere gratitude to the students and parents for your trust in us, to the shareholders for your continuous support, and to the board members, management team, teachers and staff for your commitment and effort in the past year. Hailiang Education expects to firmly root its development in China’s private education industry, actively promotes the internationalization of our schools, and always keep our mission in mind. Meanwhile, Hailiang Education aims to continue to provide high-quality education and better educational services to its students while adhering to its fundamental principle of "everyone is talented and can effectively use their talents and potentials."

We will make efforts to achieve Mr. Feng Hailiang’s ideal, the founder of Hailiang Education, by helping students to study happily, to live healthily, to become knowledgeable, and to enter into their dream schools. At the same time, the Company will strive to fulfill parents’ satisfaction, to build a better brand image, to achieve more profitable results for our shareholders, and to make our faculty proud.

Ming Wang
Chairman and Chief Executive Officer
Hailiang Education Group Inc.

[1] COVID-19 (Corona Virus Disease 2019) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. The latest situation summary updates are available on The Centers for Disease Control and Prevention’s web page COVID-19, Wuhan, China.

About Hailiang Education Group Inc.

Hailiang Education (Nasdaq: HLG) is one of the largest primary, middle, and high school educational service providers in China. The Company primarily focuses on providing distinguished, specialized, and internationalized education. Hailiang Education is dedicated to providing students with high-quality primary, middle, and high school, and international educational services and highly valuing the quality of students’ life, study, and development. Hailiang Education adapts its education services based upon its students’ individual aptitudes. Hailiang Education is devoted to improving its students’ academic capabilities, cultural accomplishments, and international perspectives. Hailiang Education operates multilingual programs including Chinese, English, Spanish, Japanese, Korean, and French. In addition, Hailiang Education has launched various diversified high-quality courses, such as Mathematical Olympiad courses, A-level courses, Australia Victorian Certificate of Education (VCE) courses, IELTS courses, TOEFL courses, as well as SAT courses. The Company has also formed extensive cooperative network more than 200 educational institutions and universities globally. Hailiang Education is committed to making great effort to provide its students with greater opportunities to enroll in well-known domestic and international universities to further their education. For more information, please visit http://ir.hailiangedu.com.

Forward-Looking Statement

This press release contains information about Hailiang Education’s view of its future expectations, plans, and prospects that constitute forward-looking statements. These forward-looking statements are made under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts in this announcement are forward-looking statements, including but not limited to the following: general economic conditions in China, competition in the education industry in China, the expected growth of the Chinese private education market, Chinese governmental policies relating to private educational services and providers of such services, health epidemics and other outbreaks in China, the Company’s business plans, the Company’s future business development, results of operations, and financial condition, expected changes in the Company’s revenue and certain cost or expense items, its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the number of students entrusted by schools, the successful integration of acquired companies, technologies and assets into its portfolio of software and services, marketing and other business development initiatives, dependence on key personnel, the ability to attract, hire, and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property, the outcome of ongoing, or any future, litigation or arbitration, including those relating to copyright and other intellectual property rights, and other risks detailed in the Company’s filings with the U.S. Securities and Exchange Commission (the "SEC"). Hailiang Education may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are not historical facts, including statements about Hailiang Education’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, whether known or unknown, and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "will make," "will be," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "endeavor to," "is/are likely to," or other similar expressions. Further information regarding these and other risks is included in our annual report on Form 20-F and other filings with the SEC. All information provided in this press release is as of the date of this press release, and Hailiang Education undertakes no obligation to update any forward-looking statements, except as may be required under applicable law.

Contacts:

Mr. Litao Qiu
Board Secretary
Hailiang Education Group Inc.
Phone: +86-571-5812-1974
Email: [email protected]

Ms. Tina Xiao
President
Ascent Investor Relations LLC
Phone: +1-917-609-0333
Email: [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/hailiang-education-releases-2020-chinese-new-year-chairman-letter-301005786.html

Related Links :

http://ir.hailiangedu.com

Are you a Corporate Representative of Hailiang Education Group Inc., an investor, or a member of the Business Press?



Henlius successfully held its fourth Scientific Advisory Board (SAB) meeting

By | EN, PR

SHANGHAI, Feb. 18, 2020 /PRNewswire/ — Shanghai Henlius Biotech, Inc. (2696.HK, Henlius), a global biologics company specialized in the discovery and development of high-quality and affordable antibodies for the treatment of patients with cancer and autoimmune diseases, recently held its fourth Scientific Advisory Board (SAB) meeting at Bay Area where the United States (US) Research and Development (R&D) site is located. Scientists from R&D groups at Shanghai, Taipei and California sites have attended the meeting either in-person or via tele-conference.

During this all-day SAB meeting, the topics focused on the presentation and discussion of Henlius’ most advanced research projects including scientific justification, competitive landscape, data update and future plans. The SAB members provided positive acknowledgement on the broad coverage of research pipeline, diverse mechanism and differentiated strategy, and impressive progress of key projects, as well as constructive feedbacks on project priority, biological insights and resource allocation.

Dr. Scott Liu, Henlius co-founder and Chief Executive Officer, started the meeting with an introduction of Henlius, focusing on Henlius’ vision and mission of affordable innovation, company history and strategy, commercialization plan and commitment to Research. Dr. Alvin Luk, Henlius Senior Vice President and Chief Medical Officer, provided an overview on Henlius Clinical strategy and pipeline, especially HLX10 anti-PD1 programs.

Special guest of the meeting Professor Ron Levy from Stanford University gave a lecture on the antibody therapy targeting tumor and in situ vaccination targeting immune system. Dr. Levy was the driving force behind the first FDA-approved monoclonal antibody for cancer treatment, Rituximab, which happens to be the first approved biosimilar in China and the first approved product from Henlius, HLX01. He also encouraged the collaboration between biotech and academia, leveraging each other’s strength in drug development and biology understanding. His sentiment was also unanimously shared by all the SAB members, guests and Henlius participants, and Henlius already had some specific collaboration initiatives with renowned researchers from academia that can be put into place soon.

"This was a very informative and productive SAB meeting. We are very excited to know the strong progress. Let’s try to find a date that is good for everyone around mid-2020 for the next SAB meeting," Professor Kun-Liang Guan, chairman of Henlius’ SAB acknowledged.

One of the SAB members, Professor Zihai Li, also commented, "Very impressive progress and a phenomenal meeting. The entire team was so engaging and energetic. Great things are bound to happen."

The meeting was concluded by a panel discussion on a variety of topics, an acknowledgement on the impressive progress, and emphasis on the research focus and collaboration. It is decided that the frequency of the SAB meeting shall be increased and the next SAB meeting is scheduled in mid-2020.

Biographies of Scientific Advisory Board Members

Dr. Kun-Liang Guan is a Distinguished Professor of Pharmacology at the University of California, San Diego. He obtained his BS (1982) at Hangzhou University, China and Ph.D. (1989) at Purdue University. From 1992-2007, Guan was a faculty at the University of Michigan. He received the MacArthur Fellowship, the American Society of Biochemistry and Molecular Biology Young Investigator Award, Distinguished Alumni Award from Purdue University, an AAAS Fellow, and is a highly cited researcher in Molecular Biology & Genetics (Thomson Reuters). Guan studies signaling mechanisms of cell growth and tumorigenesis, particular focusing on the mTOR and Hippo pathways.

Dr. Yiping Yang, Director, Division of Hematology, Professor of Medicine, the Ohio State University. Dr. Yang received his M.D. from Zhejiang University, and Ph.D. from University of Michigan. He then completed his postdoctoral training and Internal Medicine residency at the University of Pennsylvania, and his Medical Oncology fellowship at Johns Hopkins University. He is an ABIM-certified physician with clinical interest in lymphoma and leukemia. He has been selected as America’s top oncologist since 2008. He has also served as Associate Editor for Journal of Clinical Investigation (JCI) and JCI Insight. Funded by grants from National Institute of Health and private foundations, his research focuses on cancer immunology and immunotherapy, as well as gene therapy and viral immunity. He has published more than 100 peer-reviewed papers in journals including Science, Nature Immunology, Nature Genetics, Nature Medicine, Immunity, JCI, PNAS, etc.

Dr. Weiping Zou is a faculty at the University of Michigan. His research interests are in tumor immunopathology and immunotherapy. Over the past few years, his research team has achieved important insights into cancer immunopathogenesis. His research efforts demonstrate that the tumor microenvironment is comprised of immune cells that have been reprogrammed by active tumor-mediated processes to defeat tumor immunity and promote tumor progression in a highly effective manner. These studies have helped define the nature of immune responses in the cancer microenvironment, form the concept of immunosuppressive networks in the cancer microenvironment and provide significant insights into designing current immune therapies including inhibitory B7 checkpoint blockade (PD-L1, B7-H1) to treat cancer patients. The Zou laboratory is one of the most cited research teams in the field of Cancer Immunology. Dr. Zou is/was an editorial board member for 9 scientific journals. He has delivered more than 200 invited lectures. He serves as a reviewer for more than 15 funding agencies including NIH and DOD, and for more than 50 scientific journals including New England Journal of Medicine, Cell, Science, and Nature journals. He is the AACR Cancer Immunology Chairperson-elect 2018-2019.

Dr. Zihai Li is Klotz Memorial Chair in Cancer Research, Professor and Founding Director of the Pelotonia Institute for Immuno-Oncology at The Ohio State University James Comprehensive Cancer Center. He received his Ph.D. in Microbiology & Immunology from Icahn School of Medicine at Mount Sinai, New York. He completed his internal medicine residency in the Montefiore-Einstein Medical Center and his medical oncology fellowship at the Fred Hutchinson Cancer Research Center. Prior to his current position, he was chair of the Department of Microbiology and Immunology and co-leader of the Cancer Immunology Program at the NCI-designated Hollings Cancer Center at the Medical University of South Carolina (MUSC).  He is an expert in the field of GP96/GRP94 chaperone and played important roles in advancing HSP–based cancer vaccines. He recently uncovered the roles of platelets especially the TGFbeta-GARP axis on the platelets in immune tolerance and cancer immunotherapy, and discovered CNPY2 as a key initiator of the unfolded protein response. His laboratory has been continuously funded by NIH for the last two decades. Dr. Li has served multiple leadership roles in the American Society of Clinical Oncology (ASCO) and the Chinese American Hematologist and Oncologist Network (CAHON). He has been leading the effort to establish the Committee of Overseas Experts (COE) of the Chinese Society of Clinical Oncology (CSCO) and is the elected founding chair of the CSCO COE (2018-2020).

About Henlius Scientific Advisory Board Meeting (SAB)

The Scientific Advisory Board (SAB) of Henlius was established in May 2018, which consists of world-renowned scientists or physicians including Dr. Kun-Liang Guan, Dr. Yiping Yang, Dr. Weiping Zou and Dr. Zihai Li. These experts of biology, immunology and oncology have not only brought in professional insights on Henlius research strategy, but also provided scientific guidance on antibody discovery and development, helping Henlius to develop high-quality and affordable drugs to enhance the product pipeline and bring effective combo immunotherapies to patients.

About Henlius

Henlius (2696.HK) is a leading biopharmaceutical company in China with the vision to offer high-quality, affordable and innovative biologics for patients worldwide with a focus on oncology and autoimmune diseases. Since its inception in 2010, Henlius has built an integrated and efficient global R&D platform with key facilities in Shanghai, Taipei and California. The three R&D centers closely collaborate with each other to ensure a highly productive and cost-efficient R&D process. Starting from biosimilar, Henlius presses forward with novel mAb products and immuno-oncology combination therapies with proprietary anti-PD-1 and PD-L1 mAbs as backbone. Henlius establishes a diversified product pipeline of biosimilars, bio-innovative drugs and combination therapies, and builds an integrated platform covering the whole product lifecycle including R&D, commercial-scale production and commercialization. On September 25, 2019, Henlius was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 2696.HK.

Until now, in addition to one product launched commercially, two products under New Drug Application (NDA) review and one product under Marketing Authorization Application (MAA) review, Henlius has conducted over 20 clinical studies for 14 products and 7 combination therapies worldwide. HLX01 (rituximab injection), the first product of Henlius, has been granted approval by the NMPA as the first approved biosimilar in China. HLX03 (adalimumab injection) and HLX02 (trastuzumab for injection) have their NDA under priority review by the NMPA. HLX02 is also the first China-manufactured biosimilar developed in a global setting. In June 2019, the MAA for HLX02 was accepted for review by EMA. Moreover, Henlius advances immuno-oncology combination therapies with proprietary mAbs including HLX10 (anti-PD-1 mAb) as backbone in combination with chemotherapy and other mAbs including HLX04 (bevacizumab biosimilar) and HLX07 (anti-EGFR mab). The global multi-center clinical trials are ongoing in various countries and regions worldwide.

 

Cision View original content:http://www.prnewswire.com/news-releases/henlius-successfully-held-its-fourth-scientific-advisory-board-sab-meeting-301006615.html

Related Links :

www.henlius.com

Are you a Corporate Representative of Henlius, an investor, or a member of the Business Press?



iClick Interactive Announces Early Convertible Bond Conversion by Key Investors

By | EN, PR

This early conversion will not only help enhance iClick’s balance sheet with a decreased debt level but also better align investors’ interests

HONG KONG, Feb. 18, 2020 /PRNewswire/ — iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that Marine Central Limited and Tech Famous Limited have voluntarily elected to convert an aggregate of $30 million, which is the entire outstanding principal amount of the convertible bonds the Company issued to them on November 11, 2019 and December 12, 2019, respectively (collectively, the "Notes"), into Class A ordinary shares, par value US$0.001 per share, of the Company at a price of US$7.8 per share, which is at an approximately 7% premium to the 14-day VWAP of the Company’s American Depositary Shares, each representing one-half of a Class A ordinary share of the Company, as of February 14, 2020.

"This early conversion sends a clear signal to the market that our important investors have the utmost confidence in our ability to execute and unlock shareholder value, would like to support our development, and believe the stock is currently underpriced.  This transaction will also serve to substantially reduce the debt on our balance sheet, availing capital to promote the growth of our core business, as well as various new corporate development initiatives," said Jian "T.J." Tang, iClick’s Chief Executive Officer and Co-Founder.

The Notes originally bore interest at the rate of 5.0% per annum and were convertible at the option of the holder into the Company’s ADSs, each representing one-half of a Class A ordinary share of the Company. The Notes were also callable at the option of the Company upon payment of the applicable redemption price.

About iClick Interactive Asia Group Limited

iClick Interactive Asia Group Limited (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, iClick’s proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in ten locations worldwide including Asia and Europe.

For more information, please visit ir.i-click.com.

Safe Harbor Statement

This announcement contains forward-looking statements, including those related to the Company’s business strategies, operations and financial performance. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Such statements are based upon management’s current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s fluctuations in growth; its success in implementing its mobile and new retail strategies, including extending its solutions beyond its core online marketing business; its success in structuring a CRM & Marketing Cloud platform; relative percentage of its gross billing recognized as revenue under the gross and net models; its ability to retain existing clients or attract new ones; its ability to retain content distribution channels and negotiate favorable contractual terms; market competition, including from independent online marketing technology platforms as well as large and well-established internet companies; market acceptance of online marketing technology solutions and enterprise solutions; effectiveness of its algorithms and data engines; its ability to collect and use data from various sources; ability to integrate and realize synergies from acquisitions, investments or strategic partnership; fluctuations in foreign exchange rates; and general economic conditions in China and other jurisdictions where the Company operates; and the regulatory landscape in China and other jurisdictions where the Company operates. Further information regarding these and other risks is included in the Company’s annual report on Form 20-F and other filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

In China:

In the United States:

iClick Interactive Asia Group Limited

Core IR

Lisa Li

John Marco

Phone: +86-21-3230-3931 #892

Tel: +1-516-222-2560

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/iclick-interactive-announces-early-convertible-bond-conversion-by-key-investors-301006474.html

Related Links :

http://ir.i-click.com

Are you a Corporate Representative of iClick Interactive Asia Group Limited, an investor, or a member of the Business Press?



Volition Unveils Its Epigenetic Toolbox

By | EN, PR

AUSTIN, Texas, Feb. 18, 2020 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that research on its Nu.Q(TM) Capture program has led to the development of a suite of novel epigenetic tools building on the breakthroughs announced last month on its assay platform. This epigenetic toolbox aims to initially be used in cancer diagnostics.

Dr. Mark Eccleston, one of the founding scientists of Volition and its Business Development Director commented, "I believe these exciting new tools will lead to a paradigm shift in epigenetic based blood tests and help us to establish a leadership position in the epigenetics diagnostics field. We are now processing samples and expect to announce patient data demonstrating the wide utility of these methods in the coming months."

Dr. Jake Micallef, Chief Scientific Officer at Volition added, "These Nu.Q(TM) Capture technologies have emanated from years of focused research in clinical epigenetics. We have filed several patents relating to these Nu.Q(TM) methods to add to Volition’s already extensive patent portfolio, with the aim of securing broad coverage and protection in this key area of epigenetics."

Volition has developed and has filed patent applications on its novel Nu.Q(TM) Capture based epigenetic tools, in addition to its bead-based Nu.Q(TM) assay format, to decipher the epigenetic and environmental profiles of cancer nucleosomes with the aim of using:

  • Nu.Q(TM) Capture methods to enrich cancer nucleosomes and simplify sequencing based "liquid biopsies".
  • Nu.Q(TM) Capture methods to isolate intact nucleosomes from plasma for mass spectrometry analysis in the framework of both biomarker discovery and clinical diagnostics.
  • Nu.Q(TM) Capture to measure global methylation patterns in a simple platform.
  • Nu.Q(TM) Capture to concentrate nucleosomal markers prior to our Nu.QTM assays to increase accuracy.
  • Nu.Q(TM) platform to detect and measure circulating nucleosomes and transcription factors with potential to be tissue specific, and therefore cancer specific. This, if successful could result in a simple blood test for multiple cancers.

Volition is using these tools to expand diagnostic developments that focus on circulating DNA fragment analysis, to a broader and potentially more powerful investigation of the epigenetic status of a patient’s circulating chromosome fragments, in addition to its ongoing work with its assay-based format in a range of cancers.

Further Technical Background

Cell free DNA has been widely investigated for liquid biopsy in the previous decade. The cell free DNA ("cfDNA") in circulation is derived from fragmented chromatin released as cells die. This originates mainly as a result of natural turnover of white blood cells, but also from diseased cells including cancer. The relatively large background of cfDNA from normal cells makes detection of low levels of circulating tumor DNA ("ctDNA") much more difficult, especially in the context of early disease detection and has limited the applications of liquid biopsy to detection of specific mutations in advanced disease which can be used to guide treatment in a precision medicine paradigm.

DNA is relatively unstable and only fragments protected by association with proteins (predominantly histone/DNA complexes or nucleosomes and smaller transcription factor/DNA complexes) survive in circulation. The proteins and various chemical modifications to them control access to the DNA within our chromosomes and therefore the genes that are selectively switched on and off. This epigenetic level of control determines how our genetic code is ultimately expressed and allows the formation of all the cells in our body from the same genetic code. In cancer, dysregulation of this epigenetic code can deactivate tumor suppressor genes or activate tumor promotors.

Most research into new diagnostic methods in oncology has focused on extracting the short cfDNA fragments from their associated proteins circulating in the blood of cancer patients to identify genetic information (mutations for example). This process removes the equally important epigenetic components in those circulating fragments. The discarded nucleosomes and transcription factor complexes contain an immense repository of epigenetic information. At its simplest level this is related to activation/suppression of associated genetic mutations but may also explain tissue of origin of the cfDNA and can explain why ctDNA is subtly shorter than general cfDNA. Combining both the epigenetic features of the DNA/protein complexes and the DNA sequencing can differentiate disease associated and background chromatin fragments and will provide much deeper understanding of how and why these fragments are associated with disease.

About Volition

Volition is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of NucleosomicsTM, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present. Volition is primarily focused on human diagnostics but also has a subsidiary focused on animal diagnostics.

Volition’s research and development activities are centered in Belgium, with additional offices in Texas, London and Singapore, as the company focuses on bringing its diagnostic products to market.

For more information about Volition, visit Volition’s website (http://www.volitionrx.com) or connect with us via:

Twitter: https://twitter.com/volitionrx
LinkedIn: https://www.linkedin.com/company/volitionrx
Facebook: https://www.facebook.com/VolitionRx/
YouTube: https://www.youtube.com/user/VolitionRx

The contents found at Volition’s website address, Twitter, LinkedIn, Facebook, and YouTube are not incorporated by reference into this document and should not be considered part of this document.  The addresses for Volition’s website, Twitter, LinkedIn, Facebook, and YouTube are included in this document as inactive textual references only.

Media / Investor Contacts

Louise Batchelor, Volition

[email protected]

+44 (0)7557 774620

Scott Powell, Volition

[email protected]

+1 (646) 650 1351

Joseph Green, Edison Advisors

[email protected]

+1 (646) 653 7030

 

Safe Harbor Statement

Statements in this press release may be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that concern matters that involve risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in the forward-looking statements. Words such as "expects," "anticipates," "intends," "plans," "aims," "targets," "believes," "seeks," "estimates," "optimizing," "potential," "goal," "suggests," "could," "would," "should," "may," "will" and similar expressions identify forward-looking statements. These forward-looking statements relate to the effectiveness of Volition’s blood-based diagnostic tests as well as Volition’s ability to develop and successfully commercialize such test platforms for early detection of cancer and other diseases. Volition’s actual results may differ materially from those indicated in these forward-looking statements due to numerous risks and uncertainties. For instance, if Volition fails to develop and commercialize diagnostic products, it may be unable to execute its plan of operations. Other risks and uncertainties include Volition’s failure to obtain necessary regulatory clearances or approvals to distribute and market future products in the clinical IVD or the veterinary market; a failure by the marketplace to accept the products in Volition’s development pipeline or any other diagnostic products Volition might develop; Volition’s failure to secure adequate intellectual property protection; Volition will face fierce competition and Volition’s intended products may become obsolete due to the highly competitive nature of the diagnostics market and its rapid technological change; and other risks identified in Volition’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as well as other documents that Volition files with the Securities and Exchange Commission. These statements are based on current expectations, estimates and projections about Volition’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Forward-looking statements are made as of the date of this release, and, except as required by law, Volition does not undertake an obligation to update its forward-looking statements to reflect future events or circumstances.

Nucleosomics(TM) and Nu.Q(TM) and their respective logos are trademarks and/or service marks of VolitionRx Limited and its subsidiaries. All other trademarks, service marks and trade names referred to in this press release are the property of their respective owners. Additionally, unless otherwise specified, all references to "$" refer to the legal currency of the United States of America.

 

 

Cision View original content:http://www.prnewswire.com/news-releases/volition-unveils-its-epigenetic-toolbox-301006010.html

Related Links :

http://www.volitionrx.com

Are you a Corporate Representative of VolitionRx Ltd, an investor, or a member of the Business Press?



New Cisco Annual Internet Report Forecasts 5G to Support More Than 10% of Global Mobile Connections by 2023

By | EN, PR

SAN JOSE, California, Feb. 18, 2020 /PRNewswire/ —

News Summary:
By 2023:  

  • 5G Speeds will be 13 times higher than the Average Mobile Connection
  • 66% of the global population will have Internet access – that’s a WW Internet community of 5.3 billion people
  • There will be nearly 30 billion devices/connections by 2023 – 45% of those will be mobile
  • Average broadband speeds will rise from 46 Mbps to 110 Mbps
  • Wi-Fi6 hotspots will grow 13-fold from 2020-2023 and will make up 11% of all public Wi-Fi hotspots

According to the new Cisco Annual Internet Report, 5G will support more than 10% of the world’s mobile connections by 2023. The average 5G speed will be 575 megabits per second, or 13 times faster than the average mobile connection. With advanced performance capabilities, 5G will deliver more dynamic mobile infrastructures for AI and emerging IoT applications including autonomous cars, smart cities, connected health, immersive video and more.

For the past 50 years, each decade introduced a new mobile technology with cutting-edge innovations. Mobile bandwidth requirements have evolved from voice calls and texting to ultra-high-definition (UHD) video and a variety of augmented reality/virtual reality (AR/VR) applications. Consumers and business users worldwide continue to create new demands and expectations for mobile networking. This ongoing trend is clearly highlighted by the adoption and use of mobile applications. Social networking, video streaming and downloads, business productivity, e-commerce and gaming will drive the continued growth of mobile applications with nearly 300 billion downloaded by 2023.

"What we are seeing from our research is a continuous rise in internet users, devices, connections, and more demand on the network than we could have imagined," said Roland Acra, Senior Vice President and Chief Technology Officer at Cisco. "The insights and knowledge gained by our Annual Internet Report are helping global businesses, governments and service providers prepare and secure networks for the ongoing growth in connections and applications. Strategic planning and partnerships will be essential for all organizations to capitalize on their technology innovations and investments."

Cisco Annual Internet Report Highlights (2018 – 2023)

The Cisco Annual Internet Report covers mobile, Wi-Fi and fixed broadband networking with quantitative projections on the growth of users, devices and connections as well as network performance and relevant trends over a five-year forecast period (2018 – 2023).

1.  Global mobile and internet user projections by 2023

  • More than 70 percent of the global population (5.7 billion people) will have mobile connectivity (2G, 3G, 4G or 5G).
  • 66 percent of the global population (5.3 billion people) will be internet users.

2.  Global devices and connections projections by 2023

  • There will be 3.6 networked devices/connections per person and nearly 10 devices and connections per household.
  • Nearly half (47%) of all devices and connections will be video capable.
  • Machine-to-machine (M2M) connections that support a broad range of IoT applications will represent about 50% (14.7 billion) of total global devices and connections.

3.  Global mobile projections by 2023

  • 45% of all networked devices will be mobile-connected (3G and below, 4G, 5G or Low Power Wide Area [LPWA]) and 55% will be wired or connected over Wi-Fi.
  • Global 5G connections will be 10.6% of total mobile connections, compared to 0.0% in 2018.
  • By 2023, global LPWA connections will be 14.4% of total mobile connections, compared to 2.5% in 2018.

4.  Global Wi-Fi projections by 2023

  • Global Wi-Fi hotspots will grow four-fold from 2018 to 2023. There will be nearly 628 million global public Wi-Fi hotspots, up from 169 million in 2018.
  • Global Wi-Fi6 hotspots will grow 13-fold from 2020 to 2023 and will be 11% of all public Wi-Fi hotspots.

5.  Global network performance projections (mobile, Wi-Fi, and fixed broadband) by 2023

  • Average global mobile connection speeds will more than triple from 13 Mbps (2018) to 44 Mbps (2023).
  • Average global Wi-Fi connection speeds will more than triple from 30 Mbps (2018) to 92 Mbps (2023).
  • Average global fixed broadband speeds will more than double from 46 Mbps (2018) to 110 Mbps (2023).

6.  Global cybersecurity trends from 2018 to 2019

  • Globally, the frequency of DDoS attacks increased by 39%.
  • Globally, the peak attack size increased 63%.
  • The average DDoS attack size is 1 Gbps (23% of attacks are greater than 1 Gbps); there has been 776% growth in attacks between 100 Gbps and 400 Gbps.

Cisco Annual Internet Report Forecast
The Cisco Annual Internet Report is a global, regional and country level forecast/analysis that assesses digital transformation and is developed by the same analyst team that created the Cisco Visual Networking Index (VNI) Forecast. The report covers fixed broadband, Wi-Fi, and mobile (3G and below, 4G, 5G) networking. Quantitative projections are provided on the growth of internet users, devices and connections as well as network performance and new application requirements. Qualitative analyses and assessments are also provided in four strategic areas: applications, security, infrastructure transformation, and empowering employees and teams.

Cisco Annual Internet Report Methodology
The Cisco Annual Internet Report for 2018 to 2023 relies upon independent analyst forecasts and Cisco’s own intellectual property. A detailed methodology description is included in the complete report. The Cisco® Annual Internet Report aims to provide credible industry metrics for internet growth to businesses national governments, network regulators, academic researchers, telecommunications companies, technology experts and industry/business press and analysts around the globe.

Supporting Resources

RSS feed for Cisco: http://newsroom.cisco.com/rss-feeds

About Cisco
Cisco (NASDAQ: CSCO) is the worldwide technology leader that has been making the internet work since 1984. Our people, products, and partners help society securely connect and seize tomorrow’s digital opportunity today. Discover more at newsroom.cisco.com and follow us on Twitter at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco’s trademarks can be found at www.cisco.com/go/trademarks.

Logo – https://mma.prnewswire.com/media/813707/Cisco_Logo.jpg

Are you a Corporate Representative of Cisco, an investor, or a member of the Business Press?



Youdao to Report Fourth Quarter and Fiscal Year 2019 Financial Results on February 26

By | EN, PR

HANGZHOU, China, Feb. 18, 2020 /PRNewswire/ — Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), a leading intelligent learning company in China, today announced that it will report financial results for the fourth quarter and fiscal year 2019 on Wednesday, February 26, 2020, after the close of the U.S. markets.

The earnings teleconference call with simultaneous webcast will take place at 8:00 p.m. Eastern Time on Wednesday, February 26, 2020 (Beijing/Hong Kong Time: 9:00 a.m., Thursday, February 27, 2020). Youdao’s management will be on the call to discuss the quarterly results and answer questions.

Dial-in details for the earnings conference call are as follows:

United States (toll free):

+1-888-346-8982

International:

+1-412-902-4272

Mainland China (toll free):

400-120-1203

Hong Kong (toll free):     

800-905-945

Hong Kong:

+852-3018-4992

Conference ID:

10138663

A live and archived webcast of the conference call will be available on the Company’s investor relations website at http://ir.youdao.com.

A replay of the conference call will be accessible by phone one hour after the conclusion of the live call at the following numbers, until March 4, 2020:

United States:               

+1-877-344-7529

International:

+1-412-317-0088

Replay Access Code:

10138663

About Youdao, Inc. 

Youdao, Inc. (NYSE: DAO) is a leading intelligent learning company in China dedicated to developing and using technologies to provide learning content, applications and solutions to users of all ages. Building on the popularity of its online knowledge tools such as Youdao Dictionary, Youdao Cloudnote and Youdao Translation, Youdao now offers online courses covering a wide spectrum of age groups, subject matter, learning goals and areas of interest. In addition, Youdao has developed a variety of interactive learning apps and smart learning devices. Youdao was founded in 2006 as part of NetEase, Inc. (NASDAQ: NTES), a leading internet technology company in China.

For more information, please visit: http://ir.youdao.com.

Contact for Media and Investors:

In China:

Pei Du
Youdao, Inc.
Tel: +86-10-8255-8907
E-mail: [email protected]

The Piacente Group, Inc.
Emilie Wu
Tel: +86-21-6039-8363
E-mail: [email protected]

In the United States:

The Piacente Group, Inc. 
Brandi Piacente
Tel: +1-212-481-2050
E-mail: [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/youdao-to-report-fourth-quarter-and-fiscal-year-2019-financial-results-on-february-26-301006412.html

Related Links :

http://www.youdao.com/

Are you a Corporate Representative of Youdao, Inc., an investor, or a member of the Business Press?



Canadian Solar Completes Sale of 56.3 MWp Solar Power Plant in Japan for JPY 22.3 Billion

By | EN, PR

GUELPH, Ontario, Feb. 18, 2020 /PRNewswire/ — Canadian Solar Inc. (the "Company", or "Canadian Solar") (NASDAQ: CSIQ), one of the world’s largest solar power companies, announced today it completed the sale of Yamaguchi Shin Mine, a 56.3 MWp operational solar power plant in the Yamaguchi Prefecture in Japan.

Hana Financial Investment, a subsidiary of Hana Financial Group, acquired the solar power plant for an enterprise value of approximately JPY 22.3 billion (around USD 205 million). Canadian Solar expects to recognize the revenue from the transaction in the first quarter of 2020. This sale was originally planned to close in the fourth quarter of 2019 but was delayed due to regulatory and contractual obligations required to be met prior to closing the transaction.

Yamaguchi Shin Mine reached commercial operation in May 2018 and is powered by Canadian Solar high efficiency modules. The electricity generated is being purchased by Chugoku Electric Power Company, Inc. at the rate of JPY 36.0 ($0.32) per kWh for 20 years.

Canadian Solar will continue to provide asset management as well as operational and maintenance services for the plant after the transaction. Additionally, a 5-year profit sharing agreement is in place, enabling Canadian Solar to secure additional revenue after the sale should the power plant outperform agreed upon metrics.

"Canadian Solar is excited to announce the completion of the sale of our Shin Mine project." said Dr. Shawn Qu, Chairman and Chief Executive Officer at Canadian Solar. "This transaction structure ensures that we capture stable, long-term revenue streams for our asset management and operations and maintenance services. We expect to grow this business as we work to enhance and retain greater share of the value creation throughout the life cycle of solar power plants."

About Canadian Solar Inc.

Canadian Solar was founded in 2001 in Canada and is one of the world’s largest and foremost solar power companies. It is a leading manufacturer of solar photovoltaic modules and provider of solar energy solutions and has a geographically diversified pipeline of utility-scale power projects in various stages of development. Over the past 19 years, Canadian Solar has successfully delivered over 38 GW of premium quality modules to customers in over 150 countries around the world. Canadian Solar is one of the most bankable companies in the solar industry, having been publicly listed on NASDAQ since 2006. For additional information about the Company, follow Canadian Solar on LinkedIn or visit www.canadiansolar.com.

Safe Harbor/Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially. These statements are made under the "Safe Harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by such terms as "believes," "expects," "anticipates," "intends," "estimates," the negative of these terms, or other comparable terminology. Factors that could cause actual results to differ include general business and economic conditions and the state of the solar industry; governmental support for the deployment of solar power; future available supplies of high-purity silicon; demand for end-use products by consumers and inventory levels of such products in the supply chain; changes in demand from significant customers; changes in demand from major markets such as Japan, the U.S., India and China; changes in customer order patterns; changes in product mix; capacity utilization; level of competition; pricing pressure and declines in average selling prices; delays in new product introduction; delays in utility-scale project approval process; delays in utility-scale project construction; delays in the completion of project sales; continued success in technological innovations and delivery of products with the features customers demand; shortage in supply of materials or capacity requirements; availability of financing; exchange rate fluctuations; litigation and other risks as described in the Company’s SEC filings, including its annual report on Form 20-F filed on April 25, 2019. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. Investors should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and Canadian Solar undertakes no duty to update such information, except as required under applicable law.

Cision View original content:http://www.prnewswire.com/news-releases/canadian-solar-completes-sale-of-56-3-mwp-solar-power-plant-in-japan-for-jpy-22-3-billion-301005868.html

Related Links :

http://www.canadiansolar.com

Are you a Corporate Representative of Canadian Solar Inc., an investor, or a member of the Business Press?